SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 159 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $192,000 | -28.9% | 12,800 | -58.3% | 0.03% | -15.4% |
| Q2 2017 | $270,000 | +280.3% | 30,700 | +124.1% | 0.04% | +1850.0% |
| Q1 2017 | $71,000 | -10.1% | 13,700 | -19.4% | 0.00% | -90.9% |
| Q3 2016 | $79,000 | -9.2% | 17,000 | +12.6% | 0.02% | -81.8% |
| Q2 2016 | $87,000 | -63.0% | 15,100 | -61.2% | 0.12% | +19.8% |
| Q1 2016 | $235,000 | -67.4% | 38,900 | -15.3% | 0.10% | -32.2% |
| Q1 2015 | $720,000 | +27.4% | 45,900 | +24.1% | 0.15% | -43.6% |
| Q2 2014 | $565,000 | – | 37,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |